Z
Zerigo Health
A developer of a handheld medical device used to treat psoriasis, eczema and vitiligo
About Zerigo Health
ClarifyMed, operating under the brand name Zerigo Health, is a health-tech startup that offers a unique, home-based solution for managing skin conditions like eczema and psoriasis. The company's product is a smart light therapy device, which is FDA-cleared and clinically proven to provide relief from symptoms. The device uses UVB phototherapy, a type of light therapy that has been shown to be effective in treating these skin conditions.
The company's primary clients are individuals suffering from eczema or psoriasis. However, the product is also marketed to employers and health plans, who can offer the device to their employees or members at no cost. This business model allows the company to tap into the corporate wellness market, in addition to the direct-to-consumer market.
The company generates revenue through the sale of its devices and possibly through partnerships with employers and health insurance companies. The device is designed to be user-friendly, with treatment administered at the push of a button. This convenience, combined with the ability to use the device at home, eliminates the need for clinic visits, making it an attractive option for individuals seeking an easy and effective treatment for their skin conditions.
In summary, ClarifyMed, through its Zerigo Health brand, is a health-tech company that offers a home-based, smart light therapy solution for treating eczema and psoriasis. The company serves individuals with these conditions, as well as employers and health plans, and generates revenue through the sale of its devices.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- San Diego, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 70.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Dermatology, Chronic Disease, Non-Invasive medical devices and treatments, Health Diagnostics, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Oct 2021 | $43M | $172M | General Catalyst · HIG Capital · Leverage Health Solutions · Cigna Ventures | — |
| SERIES AOther financing | Oct 2019 | $18M | $72M | 7wire Ventures · Bluestem Capital · SV Health Investors | — |
Growth signals
Latest recorded traffic for Zerigo Health is 1.6K monthly website visits, up 742.1% over the last three months. Zerigo Health's team grew 2.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
7wire Ventures
Bluestem Capital
SV Health Investors
General Catalyst
HIG Capital
Leverage Health Solutions
Cigna Ventures
Leaps by Bayer
Dragoneer Investment Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zerigo Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zerigo Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.